Source link : https://www.newshealth.biz/health-news/watch-for-psoriasis-after-cancer-immunotherapy-study-says/
PD-1 and PD-L1 immune checkpoint inhibitors (ICIs) for treating advanced cancer were associated with an increased risk of new-onset psoriasis, a large observational study from Taiwan found. In an as-started analysis, the risk for psoriasis among patients with stage III/IV cancers was two- to three-fold higher among ICI users when compared against controls who received […]
Author : News Health
Publish date : 2024-11-07 18:51:07
Copyright for syndicated content belongs to the linked Source.